Conserved pneumococcal antigen

Conserved pneumococcal antigens are a set of protein and structural components on the surface or cell wall of Streptococcus pneumoniae that exhibit little sequence diversity across most strains. These include proteins such as pneumococcal surface protein A (PspA), PspC, peptidoglycan-binding protein (PcsB), serine/threonine kinase (StkP), zinc metalloprotease A (ZmpA) and B (ZmpB), as well as cell wall components like teichoic acids. They are key for bacterial virulence, adhesion, cell wall maintenance, and evasion of host immunity. Because they are widely conserved, they are being actively studied and developed as vaccine antigens—possible alternatives or complements to capsular polysaccharide-based vaccines—intended to provide broader and serotype-independent protection against pneumococcal disease in the face of growing antibiotic resistance and capsular diversity. The ability of antibodies to these antigens to correlate with protection makes them useful biomarkers in immunological evaluations, although cellular (T-cell-mediated) immunity appears fundamental for actual colonization clearance. For structured representation, the entry "Conserved pneumococcal antigens" should be replaced with specific protein names where possible, such as "Pneumococcal surface protein A (PspA)," "Peptidoglycan-binding protein (PcsB)," etc., for unambiguous identification.

Other names

Pneumococcal surface proteinsNoncapsular antigensSpecies-common antigensDCL proteins (diverse core loci)

Immunization: induction of adaptive immune responses (antibody-mediated and T-cell mediated) against conserved protein antigens, leading to opsonization, antibody-dependent cell-mediated cytotoxicity, and enhanced clearance of bacteria